Journals
Publish with us
Publishing partnerships
About us
Blog
Arthritis
Table of Contents
Special Issues
Arthritis
/
2015
/
Article
/
Tab 2
/
Research Article
Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study
Table 2
Anti-TNFi Ab in rheumatoid arthritis patients in remission treated with infliximab or adalimumab.
ā
Infliximab
= 44
Adalimumab
= 49
Anti-TNFi Ab-pos, % (95% CI)
18 (7ā30)
(
= 8)
2 (NA)
(
= 1)
0.012